While diabetes and obesity pose many of the same risks to the body, they arent exactly the same, so its hard to know whether that also influenced the results
However, few studies have evaluated markers of inflammation such as paraoxonase-1 (PON-1), which is an antioxidant enzyme closely related to high density lipoprotein (HDL), or leptin which is involved in the mechanism of satiety and has increased levels in individuals affected by overweight or obesity [14, 19, 20]
X., Shieh, P
You should not change your dosing regimen or stop taking Wegovy as prescribed without discussing with your provider first
So, in simple terms: Zepbound = GLP-1 + GIP Retatrutide = GLP-1 + GIP + glucagon Scientists believe that this triple-action approach could be why Retatrutide is producing such impressive weight loss results in early trials
Common side effects include increased appetite, weight gain and sedation